HRT for anxiety during menopause

Key takeaways

• Declining oestrogen and progesterone directly affect the brain chemicals that regulate mood and anxiety, which is why anxiety during menopause can feel different from anything you have experienced before.
• NICE guideline NG23 (updated 2026) does not recommend antidepressants as a first line treatment for menopause related mood symptoms. HRT is the recommended approach when symptoms are hormone driven.
• HRT's effect on anxiety is real but not immediate and not universal. Most women notice meaningful mood improvements within four to twelve weeks, but getting the dose and formulation right often takes time and specialist oversight.

Anxiety that arrives seemingly out of nowhere in your 40s or 50s is one of the most common and least discussed symptoms of perimenopause and menopause. It affects roughly one in three women during the menopausal transition, according to a real world multi site study published in PMC (Pan X et al., 2023), and yet many women spend years being told it is stress, burnout, or a new anxiety disorder, and are handed antidepressants rather than having their hormones properly assessed.

This article covers why menopause causes anxiety, what the clinical evidence says about HRT as a treatment, how to tell whether your anxiety is hormone driven, and what to realistically expect from treatment. It also addresses one of the most pressing questions: why are so many menopausal women given antidepressants when guidelines say HRT should come first?

Why does menopause cause anxiety?

The connection between declining hormones and anxiety is not coincidental. It is neurological.

Oestrogen plays a direct role in regulating serotonin and noradrenaline, two of the brain's primary mood stabilising neurotransmitters. When oestrogen levels fall during perimenopause, serotonin activity can become erratic, contributing to mood instability, irritability, and anxiety. A comprehensive review published in the World Journal of Psychiatry (Borozan et al., 2024) outlines this neuro-hormonal mechanism clearly: HRT addresses mood and sleep disruption in menopausal women specifically because it stabilises the hormone fluctuations that are disrupting these pathways.

Progesterone adds another layer. It acts on GABA receptors, the brain's primary calming system, and when progesterone drops, the result can be heightened nervous system reactivity: a feeling of being permanently on edge and unable to switch off. This is distinct from generalised anxiety disorder and distinct from anxiety many women will have experienced at other points in their lives. It has a hormonal signature.

Poor sleep makes everything worse. Night sweats and broken sleep are anxiety amplifying in themselves, creating a feedback loop where poor sleep raises cortisol, cortisol disrupts hormone balance further, and the anxiety deepens. This is not a psychological weakness. It is a physiological cascade.

Is your anxiety hormone related or something else?

This distinction matters, because HRT works best for anxiety that is driven by hormonal change, not for anxiety that has other root causes.

If anxiety is new during perimenopause, alongside other symptoms such as sleep disruption, hot flushes, brain fog, joint pain, or irregular periods, there is a reasonable clinical basis for investigating a hormonal cause. The anxiety of perimenopause often has a different character from other forms. It tends to be more physical: heart racing, chest tightness, a sense of dread without a clear reason. It fluctuates with the menstrual cycle in the early stages. And it often appears in a cluster with other symptoms that do not obviously belong together.

A PMC review published in 2024 (Peltonen H et al.) takes a measured position: the evidence for HRT's positive effect on mood is more convincing than for anxiety specifically, and individual response varies depending on the type of progestogen used and the timing of treatment relative to the menopausal transition. It is important to remember that HRT is not a guaranteed fix for all anxiety, and the article would not serve you well to suggest otherwise.

If you have a long standing anxiety disorder that predates perimenopause, or if your anxiety has no accompanying hormonal symptoms, HRT alone is unlikely to be sufficient. NICE guideline NG23 (updated 2026) recommends that psychological support, including CBT, is offered alongside or instead of HRT where psychological symptoms are the primary concern. But remember, these approaches are not mutually exclusive.

What does the evidence say about HRT and anxiety?

The evidence base has grown substantially in recent years, and the picture is increasingly positive, with some important considerations.

The most clinically significant recent data is a retrospective cohort study published in the British Journal of Psychiatry (Crockett et al., 2025), involving 920 women at the UK's largest specialist menopause clinic. It assessed the impact of oestrogen with or without micronised progesterone and transdermal testosterone on depressive and anxiety symptoms. The study found significant mood improvements across both perimenopausal and postmenopausal women, and notably, the addition of testosterone to oestrogen based HRT was associated with further improvement in psychological symptoms for some women.

A 2026 study published in BJPsych International (Hendriks et al.), an observational study without a control group so findings should be treated as directional, also found that combined HRT formulations, particularly those including testosterone, were associated with substantial improvements in mental health outcomes including anxiety and depression. The authors flagged an additional finding worth noting: the rate of suicidal ideation was under-detected by standard depression screening tools in this study group, highlighting the importance of specialist assessment rather than a brief consultation.

The PMC review (Peltonen H et al., 2024) notes that the effect of HRT on anxiety is less clear than its overall effect on mood, and that the type of progestogen used may affect outcomes. This is not a reason to dismiss HRT as a treatment for anxiety. It is a reason to approach it with realistic expectations and specialist oversight, rather than assuming one prescription will resolve everything.

Where clinical depression co-exists with hormonal anxiety, a network meta analysis published in Psychiatry Research (Tseng et al., 2023) found that adding systemic oestradiol to antidepressant therapy produced substantially higher response and remission rates than either treatment alone. For women where both a clinical mood disorder and hormonal disruption are present, the combined approach outperforms either treatment in isolation.

A systematic review of seven studies presented at The Menopause Society Annual Meeting (Mejia Gomez et al., 2025) evaluating oestrogen for anxiety found evidence of benefit but noted mixed results across study designs supporting the current evidence that HRT's effect on anxiety is real but not universal.

Why are so many women given antidepressants instead?

NICE guideline NG23 (updated 2026) does not recommend antidepressants as a first-line treatment for menopause-related low mood or anxiety in women who do not have a previous history of mood disorders. The guideline recommends HRT as the primary approach for menopausal symptoms, and CBT as an evidence based option for managing the psychological symptoms. Antidepressants are not the first line recommendation.

Research published in the Journal of Affective Disorders found that menopausal women in the UK may be over prescribed antidepressants and under prescribed HRT, reflecting a gap between clinical guidelines and what is happening in every day clinical practice. This is not a reason to distrust your GP. Appointment times are short, menopause training in UK medical education has historically been limited, and the overlap between menopausal anxiety and generalised anxiety disorder can be genuinely difficult to unpick under time pressure with limited resources. Although this provides context and an explanation, it does not justify why many women who should have been offered HRT have instead been offered medication that targets a different underlying cause.

If you have been prescribed antidepressants for anxiety that you believe may be menopause related, a few things are worth knowing. First, you should never stop antidepressants without medical supervision. Second, NICE NG23 and the Tseng et al. meta analysis both support a combined HRT and antidepressant approach in some cases. Third, a proper assessment with a menopause specialist may identify if hormone driven anxiety is contributing to your symptoms, meaning antidepressants could still provide some benefit.

What to expect when starting HRT for anxiety: a realistic timeline

Anxiety relief is rarely the first thing women notice after starting HRT, and setting realistic expectations matters.

“The early weeks (roughly weeks one to four) are often an adjustment period. Oestrogen levels are stabilising, and some women notice initial mood fluctuations or mild physical side effects. This is not an indication that the treatment is not working. It is the body recalibrating.”

Katy Jackson, Clinical Director - Women's Health

Sleep tends to improve first, and this matters for anxiety specifically. When night sweats reduce and sleep becomes more consistent, the cortisol and anxiety feedback loop begins to break. Voy outcome data presented at The Menopause Society 2025 (forthcoming in Climacteric) found that 71% of members reported improved sleep after starting treatment. In the same dataset, 83% reported improved mood and emotional symptoms, and 73% reported improvement in brain fog. The experience of feeling mentally foggy, emotionally reactive, and unable to think clearly is often part of the same hormonal picture, and these improvements tend to arrive together.

By three months, 88% of Voy members felt more hormonally balanced, compared to 62% of women receiving standard care. That gap reflects what specialist-led, monitored care can deliver: the time and expertise to adjust treatment when it is not working as expected.

That last point is important. Anxiety relief from HRT often requires titration, not just initiating treatment and waiting. The formulation, the dose, and sometimes the progestogen type all affect psychological outcomes. The Crockett et al. cohort (British Journal of Psychiatry, 2025) found that some women benefited substantially from the addition of testosterone to their oestrogen-based regimen. Testosterone is often associated with men, but equally important for women's energy, mood, and libido. When levels drop during menopause, it can affect motivation, emotional resilience, and sense of self. Your specialist can assess whether testosterone therapy is appropriate as part of your care.

What if HRT doesn't fully resolve anxiety?

HRT is not a universal solution, and being honest about this builds more trust than overpromising. For some women, HRT will significantly reduce anxiety. For others, it will improve mood and sleep without fully resolving anxiety. And for a smaller group, it may have limited effect on psychological symptoms, particularly where the anxiety has roots that are not hormonal.

NICE NG23 now includes updated evidence that CBT (Cognitive Behavioural Therapy: a structured talking therapy) can reduce not only psychological symptoms but also hot flushes and night sweats. This makes it a meaningful option alongside or instead of HRT, not a fallback or a last resort.

Where clinical depression co-exists with hormonal anxiety, the Tseng et al. meta analysis supports a combined approach: HRT alongside antidepressants produces better outcomes than either treatment alone for women in this situation.

What this means practically is that if HRT does not fully resolve your anxiety, the answer is not to accept that nothing will work. It is to have a conversation with a specialist about what else may be contributing and what the evidence supports as a next step.

What does a proper menopause anxiety assessment look like?

Most women who arrive at specialist menopause care have already had at least one GP appointment where anxiety was discussed. Many have been prescribed antidepressants. Some have been told it is stress. Few have had their hormone symptoms assessed in the context of their full symptom picture.

A 45 minute consultation with a BMS trained menopause specialist is a different experience. There is time to map out when symptoms began, if relevant how they relate to the menstrual cycle, which symptoms are present together, and what has been tried. There is time to discuss the evidence on HRT formulations, testosterone, CBT, and monitoring. And there is time to address the safety questions that too often go unasked.

The BJPsych International research (Hendriks et al., 2026) highlighted something directly relevant: suicidal ideation was under-detected in menopausal women using standard screening tools. A brief appointment with standard questionnaires may simply not capture the depth of what women are experiencing. A specialist consultation designed around menopause does.

Voy's outcome data shows that 88% of members felt more hormonally balanced at three months (compared to 62% receiving standard care), and 93% reported an improvement in overall quality of life after starting treatment. Both figures are from data presented at The Menopause Society 2025, forthcoming in Climacteric. They reflect what a comprehensive, specialist led approach to menopause care, not just a single prescription, can produce.

If anxiety during menopause has been affecting your sleep, your relationships, your work, or your sense of yourself, you deserve a proper assessment.